MCI Onehealth Technologies, Inc. Class A (AIDX) AI Stock Analysis

• Market Cap: C$426.63M
• Dividend Yield: N/A
• Average Volume (3M): 303.95K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.58
• Revenue Growth: 290.03%
• EPS Growth: 54.58%
• Country: CA
• Employees: 350
• Sector: Healthcare
• Sector Strength: 40
• Industry: Healthcare Providers & Services
• EPS (TTM): -0.08
• Shares Outstanding: 265,473,000
• 10 Day Avg. Volume: 352,292
• 30 Day Avg. Volume: 303,949
• PEG Ratio: 0.71
• Price to Book (P/B): 2.67
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -18.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: C$3.36
• Price Target Upside: 133.33% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 5

• Rating: 59 Neutral
• Price Target: C$1.50 ▲(4.17%Upside)

The overall stock score reflects significant challenges in financial performance and valuation, which are partly offset by positive corporate actions and moderate technical momentum. The company's strategic acquisitions and market expansion provide a positive outlook, but profitability remains a crucial area for improvement.

Positive Factors

Revenue Growth

The company's revenue increased by 208% year-over-year, surpassing both estimates and consensus.

Strategic Acquisitions

The transformational acquisition of two segments of Orion Health and partnership with WELL Health Technologies are expected to enhance financial performance.

Negative Factors

Financial Performance

Adjusted EBITDA loss of (C$5.6M) was wider than estimates and consensus.

Revenue Expectations

Revenue is expected to be softer in the first half of the year due to a cutback on early-stage trials.

MCI Onehealth Technologies, Inc. Class A Business Overview & Revenue Model

Company Description

Healwell AI Inc., a healthcare technology company, focuses on AI and data science for preventative care. It offers AI-enabled decision support platform for healthcare providers. Healwell AI Inc. has a strategic alliance agreement with WELL Health Technologies Corp to enhance the growth and development of AI-enabled healthcare technologies. The company was formerly known as MCI Onehealth Technologies Inc. and changed its name to Healwell AI Inc. in October 2023. Healwell AI Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.

How the Company Makes Money

MCI Onehealth Technologies generates revenue through multiple streams. The primary source of income is its network of healthcare clinics and services, where it offers primary and specialty medical care to patients. The company also earns money by licensing its digital health technology solutions to other healthcare providers, enabling them to improve patient management and operational efficiency. Additionally, strategic partnerships and collaborations with other healthcare organizations and technology companies contribute to its revenue, allowing for the integration and expansion of its services across various platforms.

MCI Onehealth Technologies, Inc. Class A Financial Statement Overview

Summary

MCI Onehealth Technologies demonstrates strong revenue growth, yet struggles with profitability and cash flow management. Despite increasing assets and equity, the company faces challenges in achieving sustainable operations due to persistent losses and negative cash flows. The financial stability is bolstered by financing activities, but operational improvements are necessary for long-term success.

Income Statement

The company has shown significant revenue growth from 2023 to 2024, but this growth has not translated into profitability. The gross profit margin is reasonable, but net income remains negative, indicating ongoing challenges in managing expenses relative to revenue. EBIT and EBITDA margins are also negative, which highlights operational inefficiencies.

Balance Sheet

The debt-to-equity ratio shows a moderate level of leverage, but the company has been able to maintain a positive equity ratio. Return on equity is negative due to continued net losses, which is concerning for long-term financial health. The balance sheet reflects an increase in total assets and equity, indicating some stability.

Cash Flow

The company is experiencing negative operating cash flow and free cash flow, which is worrisome. However, there has been a significant increase in financing cash flow, which may support operations temporarily. The free cash flow to net income ratio is unfavorable, indicating that the company is not generating cash efficiently.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	38.97M	7.32M	10.42M	47.82M	38.57M
Gross Profit	17.32M	1.26M	3.71M	15.01M	64.22M
EBITDA	-18.42M	-16.11M	-13.94M	-11.44M	2.11M
Net Income	-26.29M	-31.60M	-21.09M	-15.67M	-1.03M
Balance Sheet
Total Assets	125.53M	53.70M	45.63M	60.89M	22.36M
Cash, Cash Equivalents and Short-Term Investments	9.68M	19.16M	1.80M	7.68M	1.27M
Total Debt	22.20M	20.93M	17.42M	14.35M	15.04M
Total Liabilities	51.86M	32.23M	32.13M	31.14M	22.12M
Stockholders Equity	63.89M	12.65M	11.78M	28.03M	114.00K
Cash Flow
Free Cash Flow	-23.93M	-10.86M	-9.49M	-9.47M	3.99M
Operating Cash Flow	-22.62M	-10.80M	-8.35M	-7.10M	4.22M
Investing Cash Flow	-15.37M	1.35M	-1.17M	-8.64M	-234.00K
Financing Cash Flow	28.24M	27.20M	3.78M	21.99M	-4.22M

MCI Onehealth Technologies, Inc. Class A Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1.44
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:AIDX, the sentiment is Positive. The current price of 1.44 is above the 20-day moving average (MA) of 1.36, above the 50-day MA of 1.38, and below the 200-day MA of 1.55, indicating a neutral trend. The MACD of 0.03 indicates Negative momentum. The RSI at 55.37 is Neutral, neither overbought nor oversold. The STOCH value of 64.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:AIDX.

MCI Onehealth Technologies, Inc. Class A Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AIDX	59 Neutral	C$426.63M	―	-58.84%	―	290.03%	54.58%
Sector *	50 Neutral	AU$2.58B	3.39	-57.47%	2.93%	36.73%	13.67%
RHT.H	―	C$41.56M	―		―	―	―
NPTH	―	C$14.21M	―	-3.57%	―	―	―
JUMP	―	C$4.92M	2.84	37.43%	―	―	―
CDX.H	―	C$6.74M	―		―	―	―
KOVO	―	C$12.38M	―		―	―	―

MCI Onehealth Technologies, Inc. Class A Corporate Events

HEALWELL AI Inc. Reports Strong AI Segment Growth and Acquires Full Ownership of Pentavere

HEALWELL AI Inc. announced significant improvements in its AI business segment, with revenues expected to exceed $5 million in the first half of 2025, marking a 200% year-over-year increase. The company has acquired full ownership of Pentavere Research Group Inc., enhancing its integration and commercialization efforts of AI products in healthcare, positioning itself as a leader in AI-driven preventative care.

The most recent analyst rating on (TSE:AIDX) stock is a Buy with a C$2.50 price target. To see the full list of analyst forecasts on MCI Onehealth Technologies, Inc. Class A stock, see the TSE:AIDX Stock Forecast page.

HEALWELL AI Reports Strong Shareholder Support at 2025 AGM

HEALWELL AI announced the successful voting results from its 2025 annual general meeting, where shareholders representing approximately 71% of the votes attended. All business matters, including fixing the number of directors at six, re-electing the incumbent directors, and appointing Deloitte LLP as the new auditor, were approved, indicating strong shareholder support and continuity in the company’s governance.

The most recent analyst rating on (TSE:AIDX) stock is a Buy with a C$2.50 price target. To see the full list of analyst forecasts on MCI Onehealth Technologies, Inc. Class A stock, see the TSE:AIDX Stock Forecast page.

HEALWELL AI Expands into U.S. Market with Orion Health Partnership

HEALWELL AI Inc. has announced its strategic expansion into the U.S. healthcare market by launching a suite of AI-enabled tools in collaboration with Orion Health’s established software offerings. This move is expected to enhance HEALWELL’s market presence by combining Orion Health’s extensive U.S. experience and infrastructure with HEALWELL’s AI capabilities, aiming to improve clinical outcomes and reduce administrative burdens. The expansion will focus on value-based care and population health initiatives, supported by a modular, FHIR-native repository to facilitate interoperability and real-time data sharing. HEALWELL plans to deepen its U.S. presence through strategic partnerships and acquisitions, positioning itself to support clinical research and development in the life sciences sector.

The most recent analyst rating on (TSE:AIDX) stock is a Buy with a C$2.50 price target. To see the full list of analyst forecasts on MCI Onehealth Technologies, Inc. Class A stock, see the TSE:AIDX Stock Forecast page.

HEALWELL AI Inc. Achieves Record Growth and Expands Global Reach with Orion Health Acquisition

HEALWELL reported a record revenue growth of 208% in Q1-2025, driven by acquisitions and a 224% increase in its AI and Data Science business. The acquisition of Orion Health is expected to significantly enhance HEALWELL’s financial performance and global reach, adding substantial SaaS and services revenue and expanding its customer base. Leadership changes have been announced to support the company’s growth and integration strategy. The company’s financial results exceeded expectations, with cost optimization efforts and secured financing further strengthening its financial position.

The most recent analyst rating on (TSE:AIDX) stock is a Buy with a C$2.50 price target. To see the full list of analyst forecasts on MCI Onehealth Technologies, Inc. Class A stock, see the TSE:AIDX Stock Forecast page.

HEALWELL AI to Release Q1 2025 Financial Results

HEALWELL AI Inc. is set to announce its Fiscal First Quarter 2025 financial results on May 13, 2025, and will hold a conference call and webcast to discuss the results. This announcement is significant for stakeholders as it provides insights into the company’s financial health and strategic direction, potentially impacting its market positioning and investor confidence.

HEALWELL AI Inc. Announces Strategic Leadership Changes for Growth

HEALWELL AI Inc. has announced strategic changes to its executive leadership team to drive the next phase of growth and shareholder value creation. The company has appointed James Lee as the new CEO, with Dr. Alexander Dobranowski transitioning to President, and new roles for Sacha Gera as COO and Brad Porter as CCO. These changes are intended to support the integration of HEALWELL’s units and capitalize on market opportunities following the acquisition of Orion Health, positioning the company to redefine preventative healthcare through data science and AI.